Telix Doses First Patient in SOLACE Trial for Metastatic Bone Pain
October 23, 2025 | 16:17
Telix Pharmaceuticals Limited today announces that it has dosed the first patient in a Phase 1 clinical trial of TLX090.
Mobile Version